Efficacy of a Food Supplement in Relieving Premenstrual Syndrome Symptoms

Inclusion Criteria: * Healthy female subjects * Caucasian ethnicity * Subjects of childbearing age, between 18 and 45 years (extremes included) * Subjects who experience mild/moderate Premenstrual Syndrome (PMS) symptoms for at least 3 menstrual cycles prior the beginning of the experimental phase of the study\* * Subjects who have regular menstrual cycles: 21- to 35-day intervals between two menstrual cycles and a menstrual flow duration of 2-8 days\*\* * Normal weight (BMI greater than or equal to 18.5 to 24.9 kg/m2) \*\*\* * Subjects registered with National Health Service (NHS) * Subjects certifying the truthfulness of the personal data disclosed to the investigator * Subjects able to understand the language used in the investigation centre and the information given by the investigator * Subjects able to respect the instructions given by the investigator as well as able to respect the study constraints and specific requirements * Commitment not to change the daily routine or the lifestyle * Stable pharmacological therapy (except for the pharmacological therapy in the non-inclusion criteria) for at least one month without any changes expected or planned during the study * Subjects informed about the test procedures who have signed a consent form. * Assessed by the psychologist using the Premenstrual Symptoms Screening Tool (PSST), a validated self-assessment questionnaire designed to identify women experiencing Premenstrual Syndrome (PMS). The PSST includes questions a…